ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Completed · Phase 3
Conditions studied: Neoplasms, Breast
In brief
This was a four-arm (parallel group) randomized, open-label, multicenter Phase 3 study to investigate the use of a combination of Lapatinib and Trastuzumab, a sequence of Trastuzumab followed by Lapatinib, and Lapatinib alone, compared to Trastuzumab alone in the adjuvant treatment of Human Epidermal Growth Factor Receptor 2 (HER2) positive early breast cancer.
Key facts
- Study ID
- NCT00490139
- Run by
- Novartis Pharmaceuticals
- People needed
- 8381
- Starts
- 2007-05-16
- Expected to finish
- 2021-07-01
- Last updated by the study team
- 2025-03-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Anchorage, Alaska, United States
- Novartis Investigative Site — Tucson, Arizona, United States
- Novartis Investigative Site — Jonesboro, Arkansas, United States
- Novartis Investigative Site — Duarte, California, United States
- Novartis Investigative Site — Fairfield, California, United States
- Novartis Investigative Site — La Jolla, California, United States
- Novartis Investigative Site — La Jolla, California, United States
- Novartis Investigative Site — Loma Linda, California, United States
- Novartis Investigative Site — Martinez, California, United States
- Novartis Investigative Site — Marysville, California, United States
- Novartis Investigative Site — Mountain View, California, United States
- Novartis Investigative Site — Oakland, California, United States
- Novartis Investigative Site — Pleasanton, California, United States
- Novartis Investigative Site — Sacramento, California, United States
- Novartis Investigative Site — San Francisco, California, United States
- Novartis Investigative Site — Aurora, Colorado, United States
- Novartis Investigative Site — Boulder, Colorado, United States
- Novartis Investigative Site — Colorado Springs, Colorado, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Fort Collins, Colorado, United States
- Novartis Investigative Site — Fort Collins, Colorado, United States
- Novartis Investigative Site — Thornton, Colorado, United States
- Novartis Investigative Site — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.